Folic acid supplementation and methotrexate efficacy: comment on articles by Schiff, Emery et al, and others
- PMID: 11083294
- DOI: 10.1002/1529-0131(200011)43:11<2615::AID-ANR38>3.0.CO;2-A
Folic acid supplementation and methotrexate efficacy: comment on articles by Schiff, Emery et al, and others
Comment in
-
Folic acid and folinic acid supplementation during low-dose methotrexate therapy for rheumatoid arthritis: comment on the article by van Ede et al.Arthritis Rheum. 2002 May;46(5):1413-4. doi: 10.1002/art.10280. Arthritis Rheum. 2002. PMID: 12115259 No abstract available.
Comment on
-
Function and health-related quality of life: results from a randomized controlled trial of leflunomide versus methotrexate or placebo in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group.Arthritis Rheum. 1999 Sep;42(9):1870-8. doi: 10.1002/1529-0131(199909)42:9<1870::AID-ANR11>3.0.CO;2-D. Arthritis Rheum. 1999. PMID: 10513801 Clinical Trial.
-
Clinical improvement as reflected in measures of function and health-related quality of life following treatment with leflunomide compared with methotrexate in patients with rheumatoid arthritis: sensitivity and relative efficiency to detect a treatment effect in a twelve-month, placebo-controlled trial. Leflunomide Rheumatoid Arthritis Investigators Group.Arthritis Rheum. 2000 Mar;43(3):506-14. doi: 10.1002/1529-0131(200003)43:3<506::AID-ANR5>3.0.CO;2-U. Arthritis Rheum. 2000. PMID: 10728742 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical